74 related articles for article (PubMed ID: 15067105)
21. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.
Okines AF; Ashley SE; Cunningham D; Oates J; Turner A; Webb J; Saffery C; Chua YJ; Chau I
J Clin Oncol; 2010 Sep; 28(25):3945-50. PubMed ID: 20679619
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Murakami S; Yamamoto Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1147-9. PubMed ID: 17637560
[TBL] [Abstract][Full Text] [Related]
23. Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.
Waters SH; Gillibrand A; Berry H; Kumar S; Velikova G; Dodwell DJ; Perren TJ
Cancer Chemother Pharmacol; 2009 Jul; 64(2):407-12. PubMed ID: 19455333
[TBL] [Abstract][Full Text] [Related]
24. Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer.
Ohno S; Mitsuyama S; Tamura K; Nishimura R; Tanaka M; Hamada Y; Kuroki S;
Anticancer Res; 2007; 27(2):1009-13. PubMed ID: 17465235
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.
Mariani G; Petrelli F; Zambetti M; Moliterni A; Fasolo A; Marchiano A; Valagussa P; Gianni L
Clin Breast Cancer; 2006 Oct; 7(4):321-5. PubMed ID: 17092399
[TBL] [Abstract][Full Text] [Related]
26. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
Saura C; Garcia-Saenz JA; Xu B; Harb W; Moroose R; Pluard T; Cortés J; Kiger C; Germa C; Wang K; Martin M; Baselga J; Kim SB
J Clin Oncol; 2014 Nov; 32(32):3626-33. PubMed ID: 25287822
[TBL] [Abstract][Full Text] [Related]
28. Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer.
Wardley A
Oncologist; 2006; 11 Suppl 1():20-6. PubMed ID: 16971736
[TBL] [Abstract][Full Text] [Related]
29. [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs].
Galligioni E
Tumori; 2001; 87(1 Suppl 2):S1-9. PubMed ID: 11357871
[No Abstract] [Full Text] [Related]
30. [A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)].
Hino N; Ikushima Y; Tsuyuguchi M; Sohnaka Y; Wada D; Yamasaki S; Miyake H; Ogasawara T; Yamamoto Y; Ohura R
Gan To Kagaku Ryoho; 2008 May; 35(5):809-12. PubMed ID: 18487918
[TBL] [Abstract][Full Text] [Related]
31. [Patient with haemolytic anemia and treatment with capecitabine. Review of one case and literature].
Maciá Escalante S; Rodríguez Lescure A; Martínez Banaclocha N; Gallego Plazas J; Carrato Mena A
An Med Interna; 2006 Mar; 23(3):147-8. PubMed ID: 16752453
[No Abstract] [Full Text] [Related]
32. Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Piccart MJ; Di Leo A; Beauduin M; Vindevoghel A; Michel J; Focan C; Tagnon A; Ries F; Gobert P; Finet C; Closon-Dejardin MT; Dufrane JP; Kerger J; Liebens F; Beauvois S; Bartholomeus S; Dolci S; Lobelle JP; Paesmans M; Nogaret JM
J Clin Oncol; 2001 Jun; 19(12):3103-10. PubMed ID: 11408507
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
34. Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy (CEX Therapy) as Neoadjuvant Chemotherapy for HER-2-Negative Breast Cancer: A Retrospective, Single-Center Study.
Yokoyama T; Makino H; Seki N; Ueda J; Hosone M; Katayama H; Takei H; Yoshida H
J Nippon Med Sch; 2020 May; 87(2):73-79. PubMed ID: 31776320
[TBL] [Abstract][Full Text] [Related]
35. A phase I study of capecitabine combined with CPT-11 in metastatic breast cancer pretreated with anthracyclines and taxanes.
Kashiwaba M; Inaba T; Komatsu H; Ishida K; Kawagishi R; Matsui Y; Uesugi N; Sugai T; Wakabayashi G
Oncology; 2014; 86(4):206-11. PubMed ID: 24820348
[TBL] [Abstract][Full Text] [Related]
36. Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.
Venturini M; Durando A; Garrone O; Colozza MA; Contu A; Stevani I; Genta F; Bighin C; Lambiase A; Del Mastro L
Cancer; 2003 Mar; 97(5):1174-80. PubMed ID: 12599222
[TBL] [Abstract][Full Text] [Related]
37. [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
Akahane T; Chiba T; Yano H; Hashimoto Y
Gan To Kagaku Ryoho; 2007 Mar; 34(3):435-8. PubMed ID: 17353638
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study.
Bonneterre J; Tubiana-Hulin M; Catimel G
Oncology; 2004; 66(3):185-91. PubMed ID: 15218308
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
Villman K; Ohd JF; Lidbrink E; Malmberg L; Lindh B; Blomqvist C; Nordgren H; Bergh J; Bergström D; Ahlgren J
Eur J Cancer; 2007 May; 43(7):1153-60. PubMed ID: 17398088
[TBL] [Abstract][Full Text] [Related]
40. Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.
Yoshimoto M; Takao S; Hirata M; Okamoto Y; Yamashita S; Kawaguchi Y; Takami M; Furusawa H; Morita S; Abe C; Sakamoto J
Cancer Chemother Pharmacol; 2012 Aug; 70(2):331-8. PubMed ID: 22526409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
